Cg Oncology Inc. Earnings

Cg Oncology Inc.’s revenue jumped 3774.42% since last year same period to $1.67Mn in the Q3 2025. On a quarterly growth basis, Cg Oncology Inc. has generated +Inf% jump in its revenue since last 3-months.

Cg Oncology Inc.’s net profit fell -114.69% since last year same period to $-43.81Mn in the Q3 2025. On a quarterly growth basis, Cg Oncology Inc. has generated -5.75% fall in its net profits since last 3-months.

Cg Oncology Inc.’s net profit margin jumped 94.46% since last year same period to -2629.53% in the Q3 2025. On a quarterly growth basis, Cg Oncology Inc. has generated NaN% jump in its net profit margins since last 3-months.

Cg Oncology Inc.’s earning per share (EPS) estimates for the current quarter stand at 0 - a 100% jump from last quarter’s estimates.

Cg Oncology Inc.’s earning per share (EPS) estimates for the current year stand at 0.

Cg Oncology Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Cg Oncology Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.